Manufacturer record
Carewin Pharmaceuticals (Guj) Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Carewin Pharmaceuticals (Guj) Pvt. Ltd (Gujarat) were declared Not of Standard Quality between July 2024 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Carewin Pharmaceuticals (Guj) Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sodium Bicarbonate Injection I.P | 524Mfg 2025-08 · Exp 2027-07 | Description and Test for Particulate matterDescription | DTL, Bengaluru, KarnatakaState lab | Jan 2026 |
| Acetyl Cysteine Injection BP | 529Mfg 2025-10 · Exp 2027-09 | The sample does not conform to B.P. with respect to the test for Sterility.Sterility | CDL, KolkataCDSCO lab | Jan 2026 |
| Sodium Bicarbonate Injection Ip (8.4% w/v) (Sodacab 8.4%) | 409Mfg 2024-07 · Exp 2026-06 | DescriptionDescription | KarnatakaState lab | Jul 2025 |
| Pheniramine Maleate Injection IP (Care Vil) | 401Mfg 2024-07 · Exp 2026-06 | SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| Lingocaine & Adrenaline Injection IP (Lignocop- ADR) | 305Mfg 2023-12 · Exp 2025-11 | Assay of AdrenalineAssay | CDTL MumbaiCDSCO lab | Jul 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.